Ligand Pharmaceuticals (LGNYZ) EPS (Basic) (2016 - 2025)
Historic EPS (Basic) for Ligand Pharmaceuticals (LGNYZ) over the last 16 years, with Q3 2025 value amounting to $5.99.
- Ligand Pharmaceuticals' EPS (Basic) rose 163589.74% to $5.99 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.31, marking a year-over-year decrease of 1216.73%. This contributed to the annual value of -$0.22 for FY2024, which is 10708.84% down from last year.
- According to the latest figures from Q3 2025, Ligand Pharmaceuticals' EPS (Basic) is $5.99, which was up 163589.74% from $0.25 recorded in Q2 2025.
- In the past 5 years, Ligand Pharmaceuticals' EPS (Basic) ranged from a high of $5.99 in Q3 2025 and a low of -$2.88 during Q2 2024
- For the 5-year period, Ligand Pharmaceuticals' EPS (Basic) averaged around $0.63, with its median value being $0.25 (2025).
- Per our database at Business Quant, Ligand Pharmaceuticals' EPS (Basic) crashed by 231538.46% in 2024 and then soared by 163589.74% in 2025.
- Quarter analysis of 5 years shows Ligand Pharmaceuticals' EPS (Basic) stood at -$0.13 in 2021, then tumbled by 30.88% to -$0.17 in 2022, then skyrocketed by 694.47% to $1.04 in 2023, then crashed by 263.44% to -$1.7 in 2024, then soared by 452.41% to $5.99 in 2025.
- Its last three reported values are $5.99 in Q3 2025, $0.25 for Q2 2025, and -$2.21 during Q1 2025.